Dexmedetomidine Related Polyuria and Hypernatremia in Intensive Care Unit. | Zendy

Mubashar Dilawar | Zendy; Muhammad Mohsin Riaz | Zendy; Omer Sabir | Zendy; Muhammad Bilal Basit | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Dexmedetomidine Related Polyuria and Hypernatremia in Intensive Care Unit.

Author(s) -

Mubashar Dilawar,

Muhammad Mohsin Riaz,

Omer Sabir,

Muhammad Bilal Basit

Publication year - 2021

Publication title -

pakistan journal of kidney diseases

Language(s) - English

Resource type - Journals

eISSN - 2708-3020

pISSN - 2617-0329

DOI - 10.53778/pjkd502142

Subject(s) - dexmedetomidine , polyuria , medicine , diabetes insipidus , hypernatremia , vasopressin , anesthesia , sedation , polydipsia , intensive care unit , anesthetic , intensive care medicine , diabetes mellitus , endocrinology , chemistry , organic chemistry , sodium

Dexmedetomidine is commonly used sedative nowadays. It’s being used as an anesthetic for surgical procedures and frequently being used in ICU Settings for sedation, and analgesia. Dexmedetomidine is a highly selective, alpha-2 agonist that also blocks arginine-vasopressin release. Dexmedetomidine is suspected to cause diabetes insipidus leading to polyuria and hypernatremia. We report a case of Diabetes Insipidus associated with use of dexmedetomidine.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research